Earli

AI-designed genetic switches that program cancer cells to self-destruct

Built from URL

Artificial intelligence and machine learningOncologyAIBiotechHealthTechDrug Discovery

Breyer CapitalAI, AI Health, and Quantum

Aboutbreyer_capital_import

Earli is a biotechnology company born out of Stanford University focused on making cancer detectable, localizable and therefore treatable at an early stage.

ProblemBuilt from URL

Current cancer treatments struggle to target only malignant cells without harming healthy tissue, as normal and cancer growth are genetically intertwined.

See something off about this company?